FDA Warns of Balloon Bursts in Edwards Delivery Systems
The FDA issued a warning for the Commander M delivery system after reports of balloon bursts linked to one death.
Updated on Oct. 15, 2026 in Heart Disease
The U.S. FDA has issued a warning regarding the Commander M delivery system used in SAPIEN M3 procedures following reports of balloons bursting during inflation. Edwards Lifesciences has recalled the devices after three such incidents led to one death and one serious injury.
Why it matters
The recall aims to prevent further complications as balloon bursts can obstruct blood vessels or prevent the successful retrieval of the medical device during procedures. Healthcare providers are instructed to remove affected inventory from use immediately.
The FDA warning follows three confirmed reports of balloon bursts occurring during device inflation. These incidents have resulted in one reported death and one serious injury to date.
The players
Edwards Lifesciences
This is a global medical technology company that specializes in structural heart disease and critical care monitoring.
U.S. FDA
The Food and Drug Administration is the federal agency responsible for protecting public health by ensuring the safety and efficacy of medical devices.
The details
The affected Commander M delivery systems are components of the SAPIEN M3 transcatheter mitral valve replacement system. Edwards Lifesciences has requested that all customers stop using these devices and return them to the manufacturer to address the risk of vessel blockage or retrieval failure.
Timeline
December 2025: SAPIEN M3 system received US approval.
October 5, 2026: Reported date for one death and one injury.
October 8, 2026: FDA issued a warning.
Health Landscape
This recall impacts the clinical deployment of the SAPIEN M3 transcatheter mitral valve replacement system. It marks a critical safety intervention for a system that only received regulatory approval in December 2025.
Patients who have recently undergone or are scheduled for procedures involving the SAPIEN M3 system should consult their medical provider regarding potential safety implications. The recall specifically requires hospitals and clinics to return affected delivery hardware to the manufacturer.
The takeaway
Medical device safety relies on the prompt reporting and removal of hardware that fails during critical procedures. Patients and providers should verify that any equipment used in valve replacement surgeries is not subject to current recall notices.
Further reading
Learn more about the latest developments in cardiac care on the Heart Disease page.
